General Information of the Compound
Compound ID
CP0386284
Compound Name
2-(4,4-bis(4-fluorophenyl)-4,5-dihydro-1H-imidazol-2-yl)pyrimidine
    Show/Hide
Structure
Formula
C19H14F2N4
Molecular Weight
336.345
Canonical SMILES
Fc1ccc(cc1)C1(CNC(=N1)c1ncccn1)c1ccc(F)cc1
    Show/Hide
InChI
InChI=1S/C19H14F2N4/c20-15-6-2-13(3-7-15)19(14-4-8-16(21)9-5-14)12-24-18(25-19)17-22-10-1-11-23-17/h1-11H,12H2,(H,24,25)
    Show/Hide
InChIKey
YPIYQXVZTNAINT-UHFFFAOYSA-N
Physicochemical Property
logP
3.0484
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
50.17
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44573607
ChEMBL ID
CHEMBL522192
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01795, Neuropeptide Y receptor type 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000440 LM Homo sapiens (Human)  1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS